(Significant but lower urgency)
Published by the , this list categorizes antibiotic-resistant bacteria into tiers to guide and prioritize research & development (R&D) of new antimicrobials. It was first released in 2017 and updated in 2024. who priority pathogens list for r&d of new antibiotics
(Highest public health threat)
(Added in 2024) 2. High Priority
The list serves as a roadmap for scientists, investors, and policymakers to focus on bacteria for which new treatments are most desperately needed. 1. Critical Priority (Significant but lower urgency) Published by the ,
The is a strategic global catalog designed to steer the research and development (R&D) of new antibiotics toward the most dangerous drug-resistant bacteria. High Priority The list serves as a roadmap
Updated in , the list categorizes 24 antibiotic-resistant pathogens into three priority tiers— Critical , High , and Medium —based on their public health impact and the status of current treatment pipelines. 🦠 The 2024 Priority Categories